This content is from:APP亚博娱乐

Teva Secures $1.5B Credit Facility

Teva Pharmaceutical Industries has secured a credit facility worth $1.5 billion.

    Teva Pharmaceutical Industrieshas secured a credit facility worth $1.5 billion,Bloombergreports. The Israeli pharmaceutical company will refinance its debt at more favorable terms for the unsecured revolving loan.

    CitigroupandHSBC Holdingsare co-coordinators and book-runners of the three-year term credit line.Barclays Capital,BNP Paribas,Credit Suisse,Goldman Sachs,JPMorgan Chase,Morgan Stanley,BankHapoalim BMandBank Leumi Le-Israelare acting as lenders to Teva during the deal’s syndication.

    Click here for the story fromBloomberg.

    Click here for additional coverage fromReuters.

    Related Content